Research and Development

Showing 15 posts of 9596 posts found.

AstraZeneca posts drug failures, takes $382m hit

December 20, 2011 Research and Development, Sales and Marketing AstraZeneca, depression, ovarian cancer

AstraZeneca has taken a major blow to its late stage pipeline, with one of its key cancer drugs now being …
Gilenya picture

Key product launches of 2011

December 19, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Actos, Benlysta, Brilique, Eliquis, Eylea, Incivek, Jevtana, Multaq, Victrelis, Xalkori, Yervoy, Zytiga, avastin, gilenya, key products

 Avastin 2011 saw a handful of high profile drugs suffer because of new safety and efficacy concerns. Chief among these …

Vertex chief to step down; names Jeffrey Leiden as new leader

December 19, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Abbott, Vertex

Vertex has named a new chief executive to succeed Matthew Emmens, who will retire early next year. He will be …

Amgen’s chief executive and chairman Kevin Sharer to retire

December 16, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen

Kevin Sharer, Amgen’s chairman and chief executive, has announced his retirement next year, leading the way for Robert Bradway to …
Victrelis picture

Merck and Roche begin combination hep C trial

December 16, 2011 Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis

Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …

Roche makes changes in its corporate executive committee

December 15, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Roche

Roche has made two new appointments in its corporate executive committee. Sophie Kornowski-Bonnet, currently general manager of Roche in France, …
k_frazier_landscape_web

Frazier defends R&D investment and attacks price pressure

December 14, 2011 Research and Development, Sales and Marketing Merck, R&D productivity, prices

Merck & Co chief executive Kenneth Frazier has expressed concern that European governments increasingly want to pay unrealistically low prices …
ianreadweb

Ian Read elected as chairman of the board at Pfizer

December 13, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Ian Read, Kindler, Pfizer

Pfizer’s chief executive and president Ian Read has been elected as the firm’s new chairman. Read succeeds George Lorch as …
Abbott picture

Abbott signs $400 million deal with Reata

December 13, 2011 Research and Development, Sales and Marketing Abbott

Abbott has signed a new deal with inflammatory specialist Reata for its portfolio of early-stage compounds. Abbott and Reata Pharmaceuticals …

Katherine Baicker elected to Lilly’s board of directors

December 12, 2011 Business Services, Research and Development, Sales and Marketing lilly

Lilly has elected Katherine Baicker as a new member of its board of directors, effective immediately. Baicker, 40, is Professor …
Tyverb picture

GSK’s Tyverb fails late-stage trial in breast cancer

December 12, 2011 Research and Development, Sales and Marketing GSK, Tyverb, breast cancer

GlaxoSmithKline’s Tyverb has failed to help women with HER2 positive breast cancer increase their survival.  The TEACH study’s primary objective …
Jim Easton picture

Who’s really in charge of the new NHS?

December 12, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS reform

Each year the health service, the Department of Health and the UK pharmaceutical industry get an opportunity to say what …

Janssen inks $150m deal for blood cancer drug

December 12, 2011 Research and Development, Sales and Marketing Janssen, Pharmacyclics

Janssen biotech has signed a licensing deal with Pharmacyclics for its investigational blood cancer drug. The firm has paid $150 …

Dechra Pharmaceuticals PLC FDA Approval for manufacturing at Dales Pharmaceuticals

December 9, 2011 Manufacturing and Production, Research and Development FDA Approval

Dechra® Pharmaceuticals PLCFDA APPROVAL FOR MANUFACTURING AT DALES® PHARMACEUTICALS  Dales Pharmaceuticals (‘Dales’ or the ‘Company’), based in Skipton, North Yorkshire, UK, …

Dr Rajeev Venkayya to head Takeda’s new vaccine business

December 9, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Takeda

Takeda will establish a new vaccine business division in January next year and will appoint Dr Rajeev Venkayya as its …
The Gateway to Local Adoption Series

Latest content